Huei-Ju Ting

Dr. Huei-Ju Ting

National University of Tainan
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2014 in Journal of Urology
Verified
Journal Article
Closed access
CBCarla J. Beckham
Carla J. Beckham
JOJayme Olsen
Jayme Olsen
PYPeng-Nien Yin
Peng-Nien Yin
CWChia-Hao Wu
Chia-Hao Wu
HTHuei-Ju Ting
Huei-Ju Ting
YLYi-Fen Lee
Yi-Fen Lee
High grade bladder cancer is an extremely aggressive malignancy associated with high rates of morbidity and mortality. Understanding how exosomes may affect bladder cancer progression could reveal novel therapeutic targets. Exosomes derived from human bladder cancer cell lines and the urine of patients with high grade bladder cancer were assessed for the ability to promote cancer progression in standard assays. Exosomes purified from the high grade bladder cancer cell line TCC-SUP and the nonmalignant urothelial cell line SV-HUC were submitted for mass spectrometry analysis. EDIL-3 was identified and selected for further analysis. Western blot was done to determine EDIL-3 levels in urinary exosomes from patients with high grade bladder cancer. shRNA gene knockdown and recombinant EDIL-3 were applied to study EDIL-3 function. Exosomes isolated from high grade bladder cancer cells and the urine of patients with high grade bladder cancer promoted angiogenesis and migration of bladder cancer cells and endothelial cells. We silenced EDIL-3 expression and found that shEDIL-3 exosomes did not facilitate angiogenesis, and urothelial and endothelial cell migration. Moreover, exosomes purified from the urine of patients with high grade bladder cancer contained significantly higher EDIL-3 levels than exosomes from the urine of healthy controls. EDIL-3 activated epidermal growth factor receptor signaling while blockade of epidermal growth factor receptor signaling abrogated this EDIL-3 induced bladder cell migration. Exosomes derived from the urine of patients with bladder cancer contains bioactive molecules such as EDIL-3. Identifying these components and their associated oncogenic pathways could lead to novel therapeutic targets and treatment strategies.

9 April 2008 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
BBBo-Ying Bao
Bo-Ying Bao
HTHuei-Ju Ting
Huei-Ju Ting
JHJong‐Wei Hsu
Jong‐Wei Hsu
YLYi-Fen Lee
Yi-Fen Lee
Overproduction of reactive oxygen species (ROS), through either endogenous or exogenous sources, could induce DNA damage, and accumulation of DNA damage might lead to multistep carcinogenesis. The antioxidative effects of vitamin D have been suggested by epidemiological and many in vitro and in vivo laboratory studies. While exploring the antioxidative effects of vitamin D in prostate cells, we found that the active form of vitamin D, 1α, 25‐dihydroxyvitamin D3 (1,25‐VD), can protect nonmalignant human prostate epithelial cell lines, BPH‐1 and RWPE‐1, but not malignant human prostate epithelial cells, CWR22R and DU 145, from oxidative stress‐induced cell death. Glucose‐6‐phosphate dehydrogenase (G6PD), a key antioxidant enzyme, was dose‐ and time‐dependently induced by 1,25‐VD. Mechanistic studies using chromatin immunoprecipitation (ChIP) assay revealed that a direct repeat‐3 (DR3) vitamin D response element located in the first intron of the G6PD genome can be bound by liganded vitamin D receptor, thereby regulating G6PD gene expression. Increasing G6PD activity and glutathione level by 1,25‐VD can scavenge cellular ROS. Moreover, the protective effects of 1,25‐VD were abolished by dehydroepiandrosterone, a noncompetitive inhibitor of G6PD activity. Together, our results showed that 1,25‐VD can protect nonmalignant prostate cells from oxidative stress‐induced cell death by elimination of ROS‐induced cellular injuries through transcriptional activation of G6PD activity. The antioxidative effect of vitamin D strengthens its roles in cancer chemoprevention and adds to a growing list of beneficial effects of vitamin D against cancer.

3 October 2000 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
SYShuyuan Yeh
Shuyuan Yeh
YHYueh-Chiang Hu
Yueh-Chiang Hu
MRMujib Rahman
Mujib Rahman
HLHui-Kuan Lin
Hui-Kuan Lin
CHCheng-Lung Hsu
Cheng-Lung Hsu
CCChawnshang Chang
Chawnshang Chang
Although mutations of the breast cancer susceptibility gene 1 (BRCA1) may play important roles in breast and prostate cancers, the detailed mechanism linking the functions of BRCA1 to these two hormone-related tumors remains to be elucidated. Here, we report that BRCA1 interacts with androgen receptor (AR) and enhances AR target genes, such as p21 (WAF1/CIP1) , that may result in the increase of androgen-induced cell death in prostate cancer cells. The BRCA1-enhanced AR transactivation can be further induced synergistically with AR coregulators, such as CBP, ARA55, and ARA70. Together, these data suggest that the BRCA1 may function as an AR coregulator and play positive roles in androgen-induced cell death in prostate cancer cells and other androgen/AR target organs.

1 June 1999 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
CHCynthia A. Heinlein
Cynthia A. Heinlein
HTHuei-Ju Ting
Huei-Ju Ting
SYShuyuan Yeh
Shuyuan Yeh
CCChawnshang Chang
Chawnshang Chang
In an effort to understand transcriptional regulation by the peroxisome proliferator-activated receptor γ (PPARγ), we have investigated its potential interaction with coregulators and have identified ARA70 as a ligand-enhanced coactivator. ARA70 was initially described as a coactivator for the androgen receptor (AR) and is expressed in a range of tissues including adipose tissue (Yeh, S., and Chang, C. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 5517–5521). Here we show that ARA70 and PPARγ specifically interact by coimmunoprecipitation and in a mammalian two-hybrid assay. PPARγ and ARA70 interact in the absence of the PPARγ ligand 15-deoxy-Δ12,14-prostaglandin J2, although the addition of exogenous ligand enhances this interaction. Similarly, in transient transfection of DU145 cells, cotransfection of PPARγ and ARA70 induces transcription from reporter constructs driven by either three copies of an isolated PPAR response element or the natural promoter of the adipocyte fatty acid-binding protein 2 in the absence of exogenous 15-deoxy-Δ12,14-prostaglandin J2. However, this PPARγ-ARA70 transactivation is enhanced by the addition of ligand. Thus, ARA70 can function as a ligand-enhanced coactivator of PPARγ. Finally, we show that AR can squelch PPARγ-ARA70 transactivation, which suggests that cross-talk may occur between PPARγ- and AR-mediated responses in adipocytes.

1 January 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
HTHuei-Ju Ting
Huei-Ju Ting
JMJames Messing
James Messing
SYSayeda Yasmin-Karim
Sayeda Yasmin-Karim
YLYi-Fen Lee
Yi-Fen Lee
The anti-tumor effect of vitamin D has been well recognized but its translational application is hindered by side effects induced by supra-physiological concentration of vitamin D required for cancer treatment. Thus, exploring the vitamin D tumor suppressive functional mechanism can facilitate improvement of its clinical application. We screened miRNA profiles in response to vitamin D and found that a tumor suppressive miRNA, miR-98, is transcriptionally induced by 1α,25-dihydroxyvitamin D3 (1,25-VD) in LNCaP. Mechanistic dissection revealed that 1,25-VD-induced miR-98 is mediated through both a direct mechanism, enhancing the VDR binding response element in the promoter region of miR-98, and an indirect mechanism, down-regulating LIN-28 expression. Knockdown of miR-98 led to a reduction of 1,25-VD anti-growth effect and overexpression of miR-98 suppressed the LNCaP cells growth via inducing G2/M arrest. And CCNJ, a protein controlling cell mitosis, is down-regulated by miR-98 via targeting 3′-untranslated region of CCNJ. Interestingly, miR-98 levels in blood are increased upon 1,25-VD treatment in mice suggesting the biomarker potential of miR-98 in predicting 1,25-VD response. Together, the finding that growth inhibitive miR-98 is induced by 1,25-VD provides a potential therapeutic target for prostate cancer and a potential biomarker for 1,25-VD anti-tumor action.

15 January 2002 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
HTHuei-Ju Ting
Huei-Ju Ting
SYShuyuan Yeh
Shuyuan Yeh
KNKazuo Nishimura
Kazuo Nishimura
CCChawnshang Chang
Chawnshang Chang
Activation of androgen receptor (AR) via androgen in muscle cells has been closely linked to their growth and differentiation. Here, we report the cloning and characterization of supervillin (SV), a 205-kDa actin-binding protein, as an AR coregulator from the skeletal muscle cDNA library. Mammalian two-hybrid and glutathione S -transferase pull-down assays indicate a domain within SV (amino acids 594-1268) can interact with AR N terminus and DNA-binding domain–ligand-binding domain in a ligand-enhanced manner. Subcellular colocalization studies with fluorescence staining indicate SV can colocalize with AR in the presence of 5α-dihydrotestosterone in COS-1 cells. The functional reporter assays showed full-length SV and the SV peptide (amino acids 831-1281) within the interaction domain can enhance AR transactivation. Furthermore, SV can enhance the endogenous AR target gene, p27 KIP1 , expression in prostate PC-3(AR2) cells. SV preferentially enhanced AR rather than other tested nuclear receptors and could be induced by natural androgens better than other steroids. SV can also cooperate with other AR coregulators, such as ARA55 or ARA70, to enhance AR transactivation further. Unlike SRC-1 that can enhance the interaction between AR N terminus and AR C terminus, SV shows a mild suppressive effect on N–C interactions, suggesting SV may go through a different mechanism to enhance AR transactivation. Together, our data demonstrate that SV is an AR coregulator that can enhance AR transactivation in muscle and other cells.